Medpace (MEDP) Operating Margin (2015 - 2026)
Medpace (MEDP) operating margin from Sep 30, 2015 to Mar 31, 2026. The current Medpace (MEDP) operating margin is 20.03%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Medpace (MEDP)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 21.14% | -0.22% |
| 2024 | 21.19% | +18.63% |
| 2023 | 17.86% | -6.43% |
| 2022 | 19.09% | +9.79% |
| 2021 | 17.39% | -3.62% |
| 2020 | 18.04% | +22.05% |
| 2019 | 14.78% | +3.06% |
| 2018 | 14.34% | -4.50% |
| 2018 | 15.02% | +9.43% |
| 2018 | 13.72% | +11.24% |
| 2018 | 12.34% | -17.04% |
| 2017 | 14.87% | -4.34% |
| 2017 | 15.55% | +1.43% |
| 2017 | 15.33% | +2.51% |
| 2017 | 14.95% | +20.09% |
| 2016 | 12.45% | +117.44% |
| 2015 | 5.73% | N/A |
Comparison Medpace (MEDP) operating margin with competitors
Medpace (MEDP) operating margin is 20.03%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| IDXX | Idexx Laboratories Inc | 31.78% | +58.70% |
| SHC | Sotera Health Company | 28.16% | +40.62% |
| MTD | Mettler-Toledo International Inc | 26.00% | +29.83% |
| DHR | Danaher Corp | 22.58% | +12.76% |
| QGEN | Qiagen NV | 22.29% | +11.31% |
| A | Agilent Technologies Inc | 19.63% | -1.97% |
| ILMN | Illumina Inc | 19.16% | -4.32% |
| TMO | Thermo Fisher Scientific Inc | 16.93% | -15.46% |
| BLLN | Billiontoone Inc - Class A | 16.45% | -17.85% |
| VCYT | Veracyte Inc | 16.28% | -18.70% |
| DGX | Quest Diagnostics Inc | 13.78% | -31.19% |
| IQV | IQVIA Holdings Inc | 12.38% | -38.18% |
| CRL | Charles River Laboratories International Inc | 12.04% | -39.88% |
| LH | Laboratory Corp Of America Holdings | 10.76% | -46.27% |
| RVTY | Revvity Inc | 10.67% | -46.72% |
| ICLR | Icon Plc | 5.37% | -73.18% |
| CDNA | Caredx Inc | 1.02% | -94.91% |